tiletamine hydrochloride has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BRINA, A; MECIANI, L | 1 |
| Bedford, D; Boag, DE; Clegg, R; Packard, CJ; Shepherd, J | 1 |
2 other study(ies) available for tiletamine hydrochloride and Hyperlipemia
| Article | Year |
|---|---|
[POSSIBILITIES AND LIMITATIONS OF THE AMBULATORY TREATMENT OF DISLIPIDEMIA IN CORONARY DISEASE PATIENTS WITH TRIAC (TRIIODOTHYROACETIC ACID). II.USE OF TRIAC ASSOCIATED WITH VITAMIN A AND DIVANILLIDENE-CYCLOHEXANONE (D.V.C.E.)].
Topics: Aged; Cholesterol; Coronary Disease; Cyclohexanones; Drug Therapy; Humans; Hyperlipidemias; Lipids; Lipoproteins; Thyroid Hormones; Triiodothyronine; Vitamin A | 1964 |
Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: potential role of receptors in intermediate density lipoprotein catabolism.
Topics: Adult; Apolipoproteins B; Arginine; Cyclohexanes; Cyclohexanones; Female; Humans; Hyperlipidemias; Iodine Radioisotopes; Kinetics; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Models, Biological; Receptors, LDL; Reference Values | 1985 |